EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impaired kidney function, cerebral small vessel disease and cognitive disorders: the Framingham Heart Study

Dearbhla M Kelly iD, Adlin A Pinheiro, Marisa Koini, Christopher D Anderson, Hugo Aparicio, Edith Hofer, Daniela Kern, Deborah Blacker, Charles DeCarli, Shih-Jen Hwang, Anand Viswanathan, Mitzi M Gonzales und 5 weitere

Nephrology Dialysis Transplantation · 30.10.2024 · 39 (11) · 1911-1922

DOI: 10.1093/ndt/gfae079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 02.04.2024. Verfasst von Dearbhla M Kelly und 16 weiteren Autor:innen. Beteiligte Einrichtung: J Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Cerebral Small Vessel Diseases, Renal Insufficiency, Chronic, Glomerular Filtration Rate, Cognitive Dysfunction. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and hypothesis It remains unclear whether the relation of chronic kidney disease (CKD) with cognitive dysfunction is independent of blood pressure (BP). We evaluated kidney function in relation to premorbid BP measurements, cerebral small vessel disease (CSVD), and incident mild cognitive impairment (MCI) and dementia in Framingham Offspring Cohort participants.

Methods

We included Framingham Offspring participants free of dementia, attending an examination during midlife (exam cycle 6, baseline) for ascertainment of kidney function status, with brain magnetic resonance imaging late in life (exam cycles 7–9), cognitive outcome data, and available interim hypertension and BP assessments. We related CKD (estimated glomerular filtration rate <60 ml/min/1.73 m2) and albuminuria (urine albumin-to-creatinine ratio ≥30 mg/g) to CSVD markers and cognitive outcomes using multivariable regression analyses.

Results

Among 2604 participants (mean age 67.4 ± 9.2, 64% women, 7% had CKD, and 9% albuminuria), albuminuria was independently associated with covert infarcts [adjusted OR, 1.55 (1.00–2.38); P = 0.049] and incident MCI and dementia [adjusted hazard ratio (HR), 1.68 (1.18–2.41); P = 0.005 and 1.71, (1.11–2.64); P = 0.015, respectively]. CKD was not associated with CSVD markers but was associated with a higher risk of incident dementia [HR, 1.53 (1.02–2.29); P = 0.041]. While albuminuria was predictive of the Alzheimer's disease subtype [adjusted HR = 1.68, (1.03–2.74); P = 0.04), CKD was predictive of vascular dementia [adjusted HR, 2.78 (1.16–6.68); P = 0.023].

Conclusions

Kidney disease was associated with CSVD and cognitive disorders in asymptomatic community dwelling participants. The relation was independent of premorbid BP, suggesting that the link between kidney and brain disease may involve additional mechanisms beyond BP-related injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral Small Vessel DiseasesRenal Insufficiency, ChronicGlomerular Filtration RateCognitive DysfunctionHumansFemaleMaleAgedMiddle AgedAlbuminuriaRisk FactorsMagnetic Resonance ImagingCohort StudiesPrognosisFollow-Up StudiesCognition Disorders

Stichwörter der Autor:innen

CKDalbuminuriacerebral small vessel diseasecognitive impairmentdementiahypertension

Autor:innen und Institutionen

  • J Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  • National Heart, Lung, and Blood Institute, Framingham Heart Study, Framingham, MA, USA.
  • Department of Neurology, Medical University of Graz, Graz, Austria.
  • McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA.
  • Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.

ORCID-Profile: Dearbhla M Kelly

Förderung

  • NINDS NIH HHS
  • NIA NIH HHS
  • NHLBI NIH HHS
  • GBHI
  • Alzheimer's Association
  • Alzheimer's Society
  • NIH
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Kelly, D. M., Pinheiro, A. A., Koini, M., Anderson, C. D., Aparicio, H., Hofer, E., Kern, D., Blacker, D., DeCarli, C., Hwang, S. J., Viswanathan, A., Gonzales, M. M., Beiser, A. S., Seshadri, S., Schmidt, R., Demissie, S., & Romero, J. R. (2024). Impaired kidney function, cerebral small vessel disease and cognitive disorders: the Framingham Heart Study. Nephrology Dialysis Transplantation, 39(11), 1911-1922. https://doi.org/10.1093/ndt/gfae079

Vancouver

Kelly DM, Pinheiro AA, Koini M, Anderson CD, Aparicio H, Hofer E, et al. Impaired kidney function, cerebral small vessel disease and cognitive disorders: the Framingham Heart Study. Nephrology Dialysis Transplantation. 2024;39(11):1911-1922. doi:10.1093/ndt/gfae079

BibTeX
@article{Kelly2024,
  author = {Kelly, Dearbhla M and Pinheiro, Adlin A and Koini, Marisa and Anderson, Christopher D and Aparicio, Hugo and Hofer, Edith and Kern, Daniela and Blacker, Deborah and DeCarli, Charles and Hwang, Shih-Jen and Viswanathan, Anand and Gonzales, Mitzi M and Beiser, Alexa S and Seshadri, Sudha and Schmidt, Reinhold and Demissie, Serkalem and Romero, Jose R},
  title = {Impaired kidney function, cerebral small vessel disease and cognitive disorders: the Framingham Heart Study},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  volume = {39},
  number = {11},
  pages = {1911--1922},
  doi = {10.1093/ndt/gfae079}
}
Kostenlos starten →